MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybin

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ); (the "Company"), a leading biotech company developing psychedelic-inspired...

Related Keywords

Canada ,Matthias Liechti ,Miri Halperin Wernli ,Exchange Commission ,University Hospital Basel Liechti Lab ,Nasdaq ,Medicine Mindmed Inc ,Mind Medicine ,Clinical Pharmacology ,Executive President ,Mind Medicine Mindmed Inc ,